Capital Fund Management (CFM)’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $44.5M | Buy |
661,379
+128,983
| +24% | +$8.59M | 0.2% | 104 |
|
|
2026
Q1 | $33.4M | Buy |
532,396
+197,112
| +59% | +$13.7M | 0.15% | 151 |
|
|
2025
Q4 | $22.3M | Buy |
335,284
+90,630
| +37% | +$5.86M | 0.06% | 452 |
|
|
2025
Q3 | $16.5M | Buy |
244,654
+69,866
| +40% | +$5.53M | 0.04% | 601 |
|
|
2025
Q2 | $15.3M | Sell |
174,788
-30,776
| -15% | -$2.41M | 0.04% | 562 |
|
|
2025
Q1 | $14M | Sell |
205,564
-486,005
| -70% | -$39.7M | 0.04% | 557 |
|
|
2024
Q4 | $53.8M | Buy |
691,569
+300,683
| +77% | +$22.3M | 0.14% | 209 |
|
|
2024
Q3 | $26.2M | Buy |
390,886
+127,056
| +48% | +$10.4M | 0.07% | 362 |
|
|
2024
Q2 | $29.9M | Buy |
263,830
+221,989
| +531% | +$28.1M | 0.09% | 304 |
|
|
2024
Q1 | $5.8M | Buy |
+41,841
| New | +$5.26M | 0.02% | 983 |
|
|
2023
Q4 | – | Sell |
-360,198
| Closed | -$36.8M | – | 2151 |
|
|
2023
Q3 | $33.6M | Buy |
360,198
+271,346
| +305% | +$30.6M | 0.12% | 223 |
|
|
2023
Q2 | $11.4M | Sell |
88,852
-5,086
| -5% | -$615K | 0.05% | 516 |
|
|
2023
Q1 | $10.9M | Buy |
93,938
+63,749
| +211% | +$7.14M | 0.05% | 461 |
|
|
2022
Q4 | $3.42M | Buy |
+30,189
| New | +$3.31M | 0.02% | 762 |
|
|
2022
Q3 | – | Sell |
-200,226
| Closed | -$17M | – | 1463 |
|
|
2022
Q2 | $14.9M | Buy |
+200,226
| New | +$18.3M | 0.14% | 201 |
|
|
2022
Q1 | – | Sell |
-149,084
| Closed | -$20M | – | 1521 |
|
|
2021
Q4 | $20M | Buy |
+149,084
| New | +$21.4M | 0.14% | 196 |
|
|
2020
Q2 | – | Sell |
-36,892
| Closed | -$2.48M | – | 1161 |
|
|
2020
Q1 | $2.48M | Buy |
+36,892
| New | +$2.3M | 0.04% | 465 |
|
|
2019
Q3 | – | Sell |
-177,120
| Closed | -$6.63M | – | 1710 |
|
|
2019
Q2 | $6.63M | Buy |
177,120
+160,400
| +959% | +$5.04M | 0.06% | 414 |
|
|
2019
Q1 | $498K | Sell |
16,720
-86,864
| -84% | -$3.05M | ﹤0.01% | 1254 |
|
|
2018
Q4 | $3.1M | Buy |
103,584
+88,292
| +577% | +$2.8M | 0.03% | 687 |
|
|
2018
Q3 | $547K | Buy |
+15,292
| New | +$474K | ﹤0.01% | 1563 |
|
|
2018
Q1 | – | Sell |
-349,392
| Closed | -$5.01M | – | 1904 |
|
|
2017
Q4 | $5.01M | Buy |
+349,392
| New | +$4.54M | 0.03% | 675 |
|
|
2017
Q1 | – | Sell |
-115,632
| Closed | -$1.73M | – | 1547 |
|
|
2016
Q4 | $1.73M | Buy |
+115,632
| New | +$2.05M | 0.01% | 818 |
|
|
2016
Q2 | – | Sell |
-230,120
| Closed | -$3.91M | – | 1574 |
|
|
2016
Q1 | $3.91M | Sell |
230,120
-896,468
| -80% | -$15M | 0.04% | 512 |
|
|
2015
Q4 | $23.1M | Buy |
1,126,588
+1,051,540
| +1,401% | +$21.9M | 0.24% | 113 |
|
|
2015
Q3 | $1.61M | Buy |
+75,048
| New | +$1.67M | 0.02% | 683 |
|
|
2015
Q2 | – | Sell |
-313,052
| Closed | -$5.5M | – | 1505 |
|
|
2015
Q1 | $4.88M | Sell |
313,052
-130,888
| -29% | -$1.98M | 0.07% | 348 |
|
|
2014
Q4 | $6.11M | Sell |
443,940
-269,200
| -38% | -$3.3M | 0.07% | 373 |
|
|
2014
Q3 | $7.13M | Buy |
713,140
+339,772
| +91% | +$3.47M | 0.08% | 313 |
|
|
2014
Q2 | $3.7M | Buy |
373,368
+107,300
| +40% | +$951K | 0.04% | 515 |
|
|
2014
Q1 | $2.75M | Buy |
+266,068
| New | +$2.75M | 0.03% | 563 |
|
Other funds holding DXCM
Capital Fund Management (CFM)'s DXCM Position: Q2 2026 in Review
Capital Fund Management (CFM) increased its DexCom (DXCM) stake by 24% in Q2 2026, buying an estimated $8.59M and bringing the position to 661,379 shares worth $44.5M. The position accounts for 0.2% of the portfolio, ranked #104.
Capital Fund Management (CFM) first reported a position in DXCM in Q1 2014 and has held it in 31 quarters since. The position peaked at $53.8M in Q4 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Capital Fund Management (CFM) held 661,379 shares of DexCom worth $44.5M as of Q2 2026.
- Capital Fund Management (CFM) bought 128,983 DexCom shares in Q2 2026, an estimated $8.59M.
- DexCom made up 0.2% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #104 holding.
- Capital Fund Management (CFM) first reported a position in DexCom in Q1 2014 and has held it in 31 quarters since.
- Capital Fund Management (CFM)'s DexCom position peaked at $53.8M in Q4 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.